Literature DB >> 15460322

The pathology of peracute experimental Clostridium perfringens type D enterotoxemia in sheep.

F A Uzal1, W R Kelly, W E Morris, J Bermudez, M Baisón.   

Abstract

The pathological findings in sheep with peracute experimental Clostridium perfringens type D enterotoxemia are described. Of 16 animals inoculated intraduodenally with a whole culture of this microorganism and a starch solution in the abomasum, 12 developed clinical signs including increased respiratory efforts, recumbency, paddling, bleating, convulsions, blindness, and opisthotonus. Diarrhea was not observed in any of the animals. The time lapse between the beginning of intraduodenal infusion and onset of clinical signs varied between 30 minutes and 26 hours, and the clinical course varied between 1 and 9 hours. Gross postmortem changes were observed in these 12 animals and included pulmonary edema; excess pericardial, peritoneal, or pleural fluid with or without strands of fibrin; liquid small intestinal contents; leptomeningeal edema; cerebellar coning; and subcapsular petechiae on kidneys. Histological changes consisted of severe edema of pleura and interlobular septa and around blood vessels and airways and acidophilic, homogeneous, proteinaceous perivascular edema in the brain. Five of 12 animals (42%) with clinical signs consistent with enterotoxemia lacked specific histological lesions in the brain. None of the intoxicated or control animals developed nephrosis. Glucose was detected in the urine of 3 of 6 animals that were tested for this analyte. These results stress the importance of the use of histological examination of the brain, coupled with epsilon toxin detection, for a definitive diagnosis of C. perfringens type D enterotoxemia in sheep.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15460322     DOI: 10.1177/104063870401600506

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  26 in total

1.  Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox.

Authors:  Dev Chandran; Sureddi Satyam Naidu; Parthasarathy Sugumar; Gudavalli Sudha Rani; Shahana Pallichera Vijayan; Deepika Mathur; Lalit C Garg; Villuppanoor Alwar Srinivasan
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

2.  Coenzyme depletion by members of the aerolysin family of pore-forming toxins leads to diminished ATP levels and cell death.

Authors:  Christine M Fennessey; Susan E Ivie; Mark S McClain
Journal:  Mol Biosyst       Date:  2012-06-11

3.  Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

Review 4.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

5.  Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release.

Authors:  Etienne Lonchamp; Jean-Luc Dupont; Laetitia Wioland; Raphaël Courjaret; Corinne Mbebi-Liegeois; Emmanuel Jover; Frédéric Doussau; Michel R Popoff; Jean-Louis Bossu; Jean de Barry; Bernard Poulain
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

6.  Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly.

Authors:  Justine M Harkness; Jihong Li; Bruce A McClane
Journal:  Anaerobe       Date:  2012-09-11       Impact factor: 3.331

7.  Development and application of an oral challenge mouse model for studying Clostridium perfringens type D infection.

Authors:  Mariano E Fernandez-Miyakawa; Sameera Sayeed; Derek J Fisher; Rachael Poon; Vicki Adams; Julian I Rood; Bruce A McClane; Julian Saputo; Francisco A Uzal
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

8.  Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.

Authors:  J P Garcia; V Adams; J Beingesser; M L Hughes; R Poon; D Lyras; A Hill; B A McClane; J I Rood; F A Uzal
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

9.  Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin.

Authors:  Susan E Ivie; Christine M Fennessey; Jinsong Sheng; Donald H Rubin; Mark S McClain
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

10.  Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats.

Authors:  Jorge Goldstein; Winston E Morris; César Fabián Loidl; Carla Tironi-Farinati; Carla Tironi-Farinatti; Bruce A McClane; Francisco A Uzal; Mariano E Fernandez Miyakawa
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.